Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device

NCT05368623 is registered in ClinicalTrials.gov with RETINA-AI Health, Inc. as lead sponsor.

NCT NCT05368623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05368623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device
Lead sponsor
RETINA-AI Health, Inc.
Phase
Observational
Overall status
Completed
Start date
November 3, 2022
Completion date
March 31, 2023
Enrollment
1,100 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetic eye problems, diabetic macular edema, diabetic retinopathy